PATENT CLAIM ANALYSIS

Application Number: 16131287
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-07
Patent Classification: ["514", "259000"]

Abstract:
The invention provides substituted imidazo[1,5-a]pyrimidines and related organic compounds, compositions containing such compounds, medical kits, and methods for using such compounds and compositions to treat medical disorders, e.g., Gaucher disease, Parkinson's disease, Lewy body disease, dementia, or multiple system atrophy, in a patient. Exemplary substituted imidazo[1,5-a]pyrimidine compounds described herein include substituted 2,4-dimethyl-N-phenylimidazo[1,5-a]pyrimidine-8-carboxamide compounds and variants thereof.

Claim (Index 6):
The compound of  claim 4 , wherein R 2  is hydrogen, and R 3  and R 4  each represent independently for each occurrence hydrogen, methyl, or ethyl.

Metadata:
- Claim Count in Document: 68.0
- Percentile: 97.0
- Lexical Diversity: 1.62
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15678474', '15523769', '15440107', '15678468', '15551132']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7951703205813683
- 35 USC 102 Novelty (BERT): 0.5455759021481228
- Combined Prediction Score: 0.7702108787380438
- Mean Citation Score: 342.03664200000014
- Max Citation Score: 373.82022
- Similarity Product: 296.838443737793

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test